Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


01.04.2019

1 Brain Res
1 Drugs
1 J Neural Transm (Vienna)
1 Lancet Neurol
5 Mov Disord
2 Neurology
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Brain Res

  1. ZHU J, Dou S, Jiang Y, Chen J, et al
    Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through inhibiting endoplasmic reticulum stress and promoting autophagy.
    Brain Res. 2019 Mar 23. pii: S0006-8993(19)30166.
    PubMed     Text format     Abstract available


    Drugs

  2. CABREIRA V, Soares-da-Silva P, Massano J
    Contemporary Options for the Management of Motor Complications in Parkinson's Disease: Updated Clinical Review.
    Drugs. 2019 Mar 23. pii: 10.1007/s40265-019-01098.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  3. CECCHINI MP, Federico A, Zanini A, Mantovani E, et al
    Olfaction and taste in Parkinson's disease: the association with mild cognitive impairment and the single cognitive domain dysfunction.
    J Neural Transm (Vienna). 2019 Mar 25. pii: 10.1007/s00702-019-01996.
    PubMed     Text format     Abstract available


    Lancet Neurol

  4. ROSS OA, Bu G
    A novel link between trafficking and Lewy body disorders.
    Lancet Neurol. 2018;17:571-573.
    PubMed     Text format    


    Mov Disord

  5. PRICE RJ, Fisher DG, Suk JS, Hanes J, et al
    Parkinson's disease gene therapy: Will focused ultrasound and nanovectors be the next frontier?
    Mov Disord. 2019 Mar 25. doi: 10.1002/mds.27675.
    PubMed     Text format    

  6. WEINTRAUB D
    Impulse control disorders in Parkinson's disease: A 20-year odyssey.
    Mov Disord. 2019 Mar 26. doi: 10.1002/mds.27668.
    PubMed     Text format    


  7. 32nd ANNUAL SYMPOSIUM ON ETIOLOGY, PATHOGENESIS, AND TREATMENT OF PARKINSON DISEASE AND OTHER MOVEMENT DISORDERS.
    Mov Disord. 2019;34.
    PubMed     Text format    

  8. POSTUMA RB, Berg D
    Prodromal Parkinson's Disease: The Decade Past, the Decade to Come.
    Mov Disord. 2019 Mar 28. doi: 10.1002/mds.27670.
    PubMed     Text format     Abstract available

  9. LANG S, Hanganu A, Gan LS, Kibreab M, et al
    Network basis of the dysexecutive and posterior cortical cognitive profiles in Parkinson's disease.
    Mov Disord. 2019 Mar 29. doi: 10.1002/mds.27674.
    PubMed     Text format     Abstract available


    Neurology

  10. CONNOR KI, Cheng EM, Barry F, Siebens HC, et al
    Randomized trial of care management to improve Parkinson disease care quality.
    Neurology. 2019 Mar 22. pii: WNL.0000000000007324.
    PubMed     Text format     Abstract available

  11. CALABRESI P, Nigro P, Schwarz HB
    A nurse-led model increases quality of care in Parkinson disease.
    Neurology. 2019 Mar 22. pii: WNL.0000000000007295.
    PubMed     Text format    


    Proc Natl Acad Sci U S A

  12. HOLLENBACH JA, Norman PJ, Creary LE, Damotte V, et al
    A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson's disease.
    Proc Natl Acad Sci U S A. 2019 Mar 25. pii: 1821778116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: